Why did Nike (NKE) shares gain 10% in January?

NYSE: NKE | Nike, Inc.  News, Ratings, and Charts

NKE – Investors are optimistic about Nike’s growth prospects following a strong finish in 2018. Category: Consumer Goods.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

What happened


Shares of Nike (NYSE:NKE) gained 10.4% in value last month, according to data provided by S&P Global Market Intelligence. To be clear, there wasn’t any company-specific news last month. Instead, Nike’s strong earnings report in late December, along with the rebound in the broader market, helped send the shares higher in January. One analyst issued a positive report on Nike last month, which likely supported the stock performance as well.

So what

Nike has made a comeback over the last year after losing market share to rival Adidas. According to Nike’s fiscal second-quarter earnings report, sales of footwear rose 15% year over year on a constant currency basis, which drove growth in total revenue of 14%.

The swoosh brand has been rolling out new sneaker styles at a blistering pace lately. The fast cadence of new releases is a result of management’s strategy to double-down on speed in innovation and getting new products to market as quickly as possible.

Now what

Investors have taken notice of the improvement. Nike stock is up 22% over the last year, beating the S&P 500, which is down about 1%. One analyst with Cowen upgraded Nike shares to outperform citing the momentum in online sales and product innovation.

Management sees a significant growth opportunity in apparel. Footwear makes up two-thirds of annual revenue, but apparel has generally grown faster for Nike over the last year. Nike’s biggest apparel category is sportswear, in which sales increased 20% year over year in the previous quarter.

Analysts expect Nike to grow revenue by 7.8% in fiscal 2019 (which ends in May). This should translate to $2.65 per share in earnings, representing an increase of 11% year over year. Analysts currently estimate Nike will grow earnings 14% per year over the next five years, while the stock currently trades for a forward price-to-earnings ratio of 26.

John Ballard has no position in any of the stocks mentioned. The Motley Fool recommends Nike. The Motley Fool has a disclosure policy.

 


Nike Inc. shares rose $0.21 (+0.25%) in after-hours trading Friday. Year-to-date, Nike, Inc. (NKE - Get Rating) has gained 11.09%, versus a 8.22% rise in the benchmark S&P 500 index during the same period.

Nike, Inc. (NKE - Get Rating) currently has a StockNews.com POWR Rating of A (Strong Buy), and is ranked #1 of 31 stocks in the Athletics & Recreation category.


This article is brought to you courtesy of The Motley Fool.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

Investors: How Low Will Stocks Go?

SPY and the rest of the index ETFs are likely in a world of hurt as the market looks poised to head lower...potentially much lower. Read on to appreciate the catalysts at play and your best investing strategy at this time.
NYSE: GLD | SPDR Gold Trust News, Ratings, and Charts

Why Gold Is Just Getting Started

There is still a good old-fashioned sense that something is truly wrong with the world economy right now, which is why gold is just getting started. Read for more details.
: CRON | Cronos Group Inc. - Common Share News, Ratings, and Charts

Why Has Wall St. Turned Bullish on Cronos Group (CRON)?

In recent weeks Wall Street has turned bullish on Cronos Group (CRON) stock, despite the cannabis sector’s slide throughout this summer.
NYSE: OAK | Oaktree Capital Group, LLC Class A  Limited Liability Company Interests News, Ratings, and Charts

8 Elite Income Stocks with 8%+ Dividend Yield

Oaktree Capital Group pays a 8% dividend yield with a history of increasing that payout by 11% a year. And that is the least attractive stock on this list of 8 elite income stocks. Read on for more.
NASDAQ: CPRX | Catalyst Pharmaceuticals, Inc. News, Ratings, and Charts

7 Stocks to Get Your Heart Racing!

Catalyst Pharma is trading 51% under its fair value target...and that is the most boring stock on this list. Read on to discover the full list of 7 with up to 155% upside.

Read More Stories


More Nike, Inc. (NKE) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All NKE News
Page generated in 1.4192 seconds.